Visible is building a solution for people with post-viral conditions to track and manage symptoms, avoid relapse and improve health outcomes.

Measuring & managing post-viral illness using wearable technology


“Myalgic encephalomyelitis” / chronic fatigue syndrome (ME/CFS) is an extremely debilitating illness, which is considered to be triggered by a virus. Before the pandemic, at least 1% of the population suffered from ME/CFS. Numbers are expected to grow dramatically with the impact of Long Covid.


There is clear evidence that these life-long conditions improve with “pacing” (the right mix of activity and rest). Visible is building a solution that includes tracking illness-specific metrics (heart rate variability, fatigue, sleep disorders and dysautonomia), managing symptoms and measuring response to treatment.

Team members

Harry Leeming
Luke Martin-Fuller

Digital Health
Year invested

More Use Cases

We are a fund built
by founders for founders

Successful founders supporting new founders in a way not yet seen in European venture capital. Let us be part of your journey!

Submit your pitch